ZNF688
gene geneOn this page
Summary
ZNF688 (zinc finger protein 688, HGNC:30489) is a protein-coding gene on chromosome 16p11.2, encoding Zinc finger protein 688 (P0C7X2). May be involved in transcriptional regulation.
Predicted to enable DNA-binding transcription factor activity. Predicted to be involved in regulation of DNA-templated transcription. Predicted to be located in nucleus.
Source: NCBI Gene 146542 — RefSeq curated summary.
At a glance
- Clinical variants (ClinVar): 34 total
- MANE Select transcript:
NM_145271
Identifiers
Gene identifiers
| Field | Value |
|---|---|
| HGNC ID | HGNC:30489 |
| Approved symbol | ZNF688 |
| Name | zinc finger protein 688 |
| Location | 16p11.2 |
| Locus type | gene with protein product |
| Status | Approved |
| Ensembl gene | ENSG00000229809 |
| Ensembl biotype | protein_coding |
| Entrez | 146542 |
Gene structure
Transcript identifiers
Ensembl transcripts: 10 — 8 protein_coding, 2 retained_intron
ENST00000223459, ENST00000562455, ENST00000563276, ENST00000563665, ENST00000563707, ENST00000566632, ENST00000567855, ENST00000897344, ENST00000897345, ENST00000897346
RefSeq mRNA: 2 — MANE Select: NM_145271
NM_001024683, NM_145271
CCDS: CCDS10684, CCDS42151
Canonical transcript exons
ENST00000223459 — 3 exons
| Exon | Start | End |
|---|---|---|
| ENSE00000704440 | 30571010 | 30571123 |
| ENSE00001520971 | 30571434 | 30571714 |
| ENSE00002603306 | 30569726 | 30570436 |
Expression profiles
Bgee: expression breadth ubiquitous, 280 present calls, max score 90.29.
FANTOM5 (CAGE): breadth ubiquitous, TPM avg 6.3064 / max 108.5483, expressed in 1726 samples.
FANTOM5 promoters (4 alternative TSS)
| Promoter ID | TPM avg | Samples expressed |
|---|---|---|
| 157068 | 4.0868 | 1612 |
| 157069 | 0.9072 | 476 |
| 157067 | 0.8189 | 519 |
| 157070 | 0.4936 | 251 |
Top tissues by expression
296 total, by Bgee expression score (0-100, higher = more expressed):
| Tissue | Anatomy ID | Expression score | Quality |
|---|---|---|---|
| sural nerve | UBERON:0015488 | 90.29 | gold quality |
| buccal mucosa cell | CL:0002336 | 89.59 | silver quality |
| right testis | UBERON:0004534 | 89.17 | gold quality |
| olfactory segment of nasal mucosa | UBERON:0005386 | 89.17 | gold quality |
| apex of heart | UBERON:0002098 | 88.29 | gold quality |
| left testis | UBERON:0004533 | 88.14 | gold quality |
| sperm | CL:0000019 | 87.89 | gold quality |
| granulocyte | CL:0000094 | 87.88 | gold quality |
| male germ cell | CL:0000015 | 87.42 | gold quality |
| right uterine tube | UBERON:0001302 | 87.01 | gold quality |
| hindlimb stylopod muscle | UBERON:0004252 | 86.81 | gold quality |
| vena cava | UBERON:0004087 | 86.59 | silver quality |
| mucosa of transverse colon | UBERON:0004991 | 86.50 | gold quality |
| testis | UBERON:0000473 | 86.32 | gold quality |
| epithelium of bronchus | UBERON:0002031 | 85.50 | gold quality |
| bronchial epithelial cell | CL:0002328 | 85.26 | gold quality |
| bronchus | UBERON:0002185 | 85.21 | gold quality |
| prefrontal cortex | UBERON:0000451 | 84.98 | gold quality |
| pancreatic ductal cell | CL:0002079 | 84.96 | silver quality |
| cerebellar hemisphere | UBERON:0002245 | 84.81 | gold quality |
| cerebellar cortex | UBERON:0002129 | 84.70 | gold quality |
| right hemisphere of cerebellum | UBERON:0014890 | 84.68 | gold quality |
| leukocyte | CL:0000738 | 84.59 | gold quality |
| monocyte | CL:0000576 | 84.58 | gold quality |
| mononuclear cell | CL:0000842 | 84.50 | gold quality |
| lower esophagus | UBERON:0013473 | 84.44 | gold quality |
| lower esophagus muscularis layer | UBERON:0035833 | 84.44 | gold quality |
| gastrocnemius | UBERON:0001388 | 84.36 | gold quality |
| muscle layer of sigmoid colon | UBERON:0035805 | 84.33 | gold quality |
| adenohypophysis | UBERON:0002196 | 84.26 | gold quality |
Single-cell (SCXA)
Detected in 1 experiment(s), a significant marker in 1.
| Experiment | Marker? | Max mean expression |
|---|---|---|
| E-ANND-3 | yes | 5.60 |
Regulation
Is transcription factor: no
miRNA regulators (miRDB)
15 targeting ZNF688, top 30 by miRDB confidence (max_score; target_count = how many genes the miRNA targets in total — lower means more specific):
| miRNA | Max score | Avg score | miRNA target_count |
|---|---|---|---|
| HSA-MIR-4713-3P | 100.00 | 65.92 | 505 |
| HSA-MIR-6756-5P | 99.82 | 67.97 | 2466 |
| HSA-MIR-3150A-3P | 99.76 | 64.44 | 1640 |
| HSA-MIR-6763-5P | 99.76 | 64.68 | 1767 |
| HSA-MIR-2681-5P | 99.75 | 67.64 | 1655 |
| HSA-MIR-6745 | 99.74 | 65.33 | 1321 |
| HSA-MIR-6766-5P | 99.68 | 67.70 | 2325 |
| HSA-MIR-363-5P | 99.46 | 64.51 | 1015 |
| HSA-MIR-584-3P | 99.35 | 67.69 | 1082 |
| HSA-MIR-7151-3P | 99.04 | 69.72 | 2370 |
| HSA-MIR-4463 | 98.56 | 66.05 | 1071 |
| HSA-MIR-4483 | 98.09 | 64.12 | 1642 |
| HSA-MIR-4253 | 97.48 | 65.11 | 692 |
| HSA-MIR-6862-5P | 97.48 | 64.84 | 713 |
| HSA-MIR-1293 | 96.16 | 64.69 | 916 |
Cross-species orthologs
13 orthologs
| Organism | Symbol | Gene ID |
|---|---|---|
| danio_rerio | znf646 | ENSDARG00000061424 |
| danio_rerio | si:dkey-89b17.4 | ENSDARG00000075545 |
| danio_rerio | zgc:66472 | ENSDARG00000075916 |
| danio_rerio | si:ch211-148l7.4 | ENSDARG00000094469 |
| danio_rerio | znf576.1 | ENSDARG00000097819 |
| mus_musculus | Zfp688 | ENSMUSG00000045251 |
| rattus_norvegicus | Zfp688 | ENSRNOG00000018379 |
| drosophila_melanogaster | az2 | FBGN0025185 |
| drosophila_melanogaster | CG2129 | FBGN0030008 |
| drosophila_melanogaster | CG1602 | FBGN0033186 |
| drosophila_melanogaster | indra | FBGN0035213 |
| drosophila_melanogaster | CG30020 | FBGN0050020 |
| drosophila_melanogaster | mld | FBGN0263490 |
Paralogs (36): ZNF302 (ENSG00000089335), ZNF184 (ENSG00000096654), CTCF (ENSG00000102974), ZNF574 (ENSG00000105732), ZBTB24 (ENSG00000112365), ZNF142 (ENSG00000115568), CTCFL (ENSG00000124092), ZNF473 (ENSG00000142528), ZNF827 (ENSG00000151612), ZNF689 (ENSG00000156853), ZNF208 (ENSG00000160321), ZNF91 (ENSG00000167232), ZNF526 (ENSG00000167625), ZNF764 (ENSG00000169951), ZNF747 (ENSG00000169955), ZNF282 (ENSG00000170265), ZNF160 (ENSG00000170949), ZNF497 (ENSG00000174586), ZBTB34 (ENSG00000177125), ZNF771 (ENSG00000179965), ZNF48 (ENSG00000180035), ZNF594 (ENSG00000180626), ZBTB37 (ENSG00000185278), ZFP92 (ENSG00000189420), ZNF107 (ENSG00000196247), ZNF729 (ENSG00000196350), ZNF569 (ENSG00000196437), ZNF420 (ENSG00000197050), ZNF785 (ENSG00000197162), ZNF665 (ENSG00000197497), ZNF181 (ENSG00000197841), ZNF347 (ENSG00000197937), ZNF84 (ENSG00000198040), ZBTB48 (ENSG00000204859), ZNF845 (ENSG00000213799), ZNF99 (ENSG00000213973)
Protein
Protein identifiers
Zinc finger protein 688 — P0C7X2 (reviewed: P0C7X2)
All UniProt accessions (6): A0A0S2Z5X4, A0A0S2Z633, H3BR26, H3BR45, H3BTK8, P0C7X2
UniProt curated annotations — full annotation on UniProt →
Function. May be involved in transcriptional regulation.
Subcellular location. Nucleus.
Similarity. Belongs to the krueppel C2H2-type zinc-finger protein family.
Isoforms (2)
| UniProt ID | Names | Canonical? |
|---|---|---|
| P0C7X2-1 | 1 | yes |
| P0C7X2-5 | 2 |
RefSeq proteins (2): NP_001019854, NP_660314* (*=MANE)
Domains & families (InterPro)
| ID | Name | Type |
|---|---|---|
| IPR001909 | KRAB | Domain |
| IPR013087 | Znf_C2H2_type | Domain |
| IPR036051 | KRAB_dom_sf | Homologous_superfamily |
| IPR036236 | Znf_C2H2_sf | Homologous_superfamily |
| IPR050169 | Krueppel_C2H2_ZnF | Family |
Pfam: PF00096, PF01352
UniProt features (14 total): region of interest 3, compositionally biased region 3, sequence conflict 2, zinc finger region 2, chain 1, domain 1, splice variant 1, sequence variant 1
Structure
Experimental structures (PDB)
0 structures.
Predicted structure (AlphaFold)
| Model | pLDDT | Fraction very-high |
|---|---|---|
| AF-P0C7X2-F1 | 59.52 | 0.01 |
Function
Pathways and Gene Ontology
Reactome pathways
1 pathways
| ID | Pathway |
|---|---|
| R-HSA-212436 | Generic Transcription Pathway |
MSigDB gene sets: 117 (showing top):
chr16p11, VDR_Q3, YY1_01, RASHI_RESPONSE_TO_IONIZING_RADIATION_6, MARTORIATI_MDM4_TARGETS_FETAL_LIVER_UP, RAAGNYNNCTTY_UNKNOWN, GOMF_SEQUENCE_SPECIFIC_DNA_BINDING, PR_Q2, VDR_Q6, GOBP_NEGATIVE_REGULATION_OF_TRANSCRIPTION_BY_RNA_POLYMERASE_II, BRUINS_UVC_RESPONSE_VIA_TP53_GROUP_B, GOBP_NEGATIVE_REGULATION_OF_NUCLEOBASE_CONTAINING_COMPOUND_METABOLIC_PROCESS, BYSTRYKH_HEMATOPOIESIS_STEM_CELL_QTL_TRANS, PDGF_UP.V1_DN, GSE13522_CTRL_VS_T_CRUZI_G_STRAIN_INF_SKIN_UP
GO Biological Process (1): regulation of DNA-templated transcription (GO:0006355)
GO Molecular Function (5): DNA binding (GO:0003677), DNA-binding transcription factor activity (GO:0003700), zinc ion binding (GO:0008270), protein binding (GO:0005515), metal ion binding (GO:0046872)
GO Cellular Component (1): nucleus (GO:0005634)
Reactome top-level categories
Rollup of top-1 pathways:
| Category | Pathways |
|---|---|
| RNA Polymerase II Transcription | 1 |
GO top-level categories
Rollup of top GO terms by namespace:
| Category | Terms |
|---|---|
| DNA-templated transcription | 1 |
| regulation of gene expression | 1 |
| regulation of RNA biosynthetic process | 1 |
| nucleic acid binding | 1 |
| transcription cis-regulatory region binding | 1 |
| regulation of DNA-templated transcription | 1 |
| transcription regulator activity | 1 |
| transition metal ion binding | 1 |
| binding | 1 |
| cation binding | 1 |
| intracellular membrane-bounded organelle | 1 |
Protein interactions and networks
STRING
298 interactions, top by confidence (×1000):
| Protein A | Protein B | Partner UniProt | Score |
|---|---|---|---|
| ZNF688 | MRPL43 | Q8N983 | 497 |
| ZNF688 | PRR20A | P86496 | 478 |
| ZNF688 | AVL9 | Q8NBF6 | 434 |
| ZNF688 | DNTTIP1 | Q9H147 | 416 |
| ZNF688 | ZNF618 | Q5T7W0 | 408 |
| ZNF688 | HECTD2 | Q5U5R9 | 400 |
| ZNF688 | RNPEPL1 | Q9HAU8 | 396 |
| ZNF688 | FAM184A | Q8NB25 | 372 |
| ZNF688 | CCDC85C | A6NKD9 | 371 |
| ZNF688 | MOSPD3 | O75425 | 367 |
| ZNF688 | ACBD7 | Q8N6N7 | 367 |
| ZNF688 | EIF1AY | O14602 | 356 |
| ZNF688 | THAP7 | Q9BT49 | 355 |
| ZNF688 | RTP4 | Q96DX8 | 323 |
| ZNF688 | PABPC1L | Q4VXU2 | 306 |
IntAct
135 interactions, top by confidence:
| A | B | Type | Score |
|---|---|---|---|
| SMARCB1 | ZNF688 | psi-mi:“MI:0915”(physical association) | 0.560 |
| TCP11 | ZNF688 | psi-mi:“MI:0915”(physical association) | 0.560 |
| AIRIM | ZNF688 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | HOXA1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| POLR1C | ZNF688 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | LMO2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | FAM90A1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | RCOR3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| BOLA2-SMG1P6 | ZNF688 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | CCDC102B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | CIB3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | PIH1D2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | ABI2 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | TENT5B | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | PFKFB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | CARD9 | psi-mi:“MI:0915”(physical association) | 0.560 |
| HSF2BP | ZNF688 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | TCEANC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | SMARCB1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | CCNC | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | MKRN3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | NFU1 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | DEF6 | psi-mi:“MI:0915”(physical association) | 0.560 |
| PHF1 | ZNF688 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | GEM | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | ZNF330 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | MYOZ3 | psi-mi:“MI:0915”(physical association) | 0.560 |
| ZNF688 | GLYCTK | psi-mi:“MI:0915”(physical association) | 0.560 |
BioGRID (120): ZNF688 (Biochemical Activity), TRIM23 (Two-hybrid), CRX (Two-hybrid), GOLGA2 (Two-hybrid), KRT31 (Two-hybrid), REL (Two-hybrid), TRIM27 (Two-hybrid), TCF4 (Two-hybrid), TCF12 (Two-hybrid), TRAF2 (Two-hybrid), CADPS (Two-hybrid), FHL5 (Two-hybrid), GMPPA (Two-hybrid), RINT1 (Two-hybrid), CCDC33 (Two-hybrid)
ESM2 similar proteins: A0A0U1RRK4, A0A1W2PPE3, A0A1W2PR82, A0A2Z4LIS9, A2VE02, A4D1S0, A5PKC7, A5PL33, A6H7B4, A6NEL2, A6QP24, A6QPM6, A8MTW9, A8MYA2, D3ZAQ5, D4AAA5, E7EW31, O75474, O75638, O89113, O94850, P0C7X2, P14652, P50617, P70339, Q2KIS6, Q3UN58, Q5JPB2, Q5VZ46, Q6GQX2, Q6NZ36, Q6ZSJ8, Q6ZW13, Q76NI1, Q7TNS8, Q80TS7, Q86UU5, Q8IWN7, Q8N6K4, Q8N944
Diamond homologs: A0JPL0, A2A761, A3KN32, A3KN36, A6NFI3, A6NM28, A6QLU5, A6QPT6, A7MBI1, A8MTY0, B2RXC5, B4DU55, E9PYI1, O14978, O60765, O75467, O75820, O95780, P0C7X2, P0DKX0, P0DPD5, P10072, P15622, P16374, P17014, P17023, P17032, P17098, P51523, P51786, P52738, P52742, Q02975, Q06732, Q08DG8, Q08ER8, Q0VCB0, Q14590, Q14929, Q29RZ4
SIGNOR signaling
0 interactions.
Enriched among interaction partners
Reactome pathways and GO biological processes over-represented among this gene’s 49 IntAct physical interaction partners (hypergeometric vs the genome-wide background, BH-FDR, gene-set size 15–500, ranked by fold). A functional readout of the neighbourhood — distinct from this gene’s own memberships above, and biased toward well-studied / hub proteins, so read it as themes rather than proof.
Reactome pathways:
| Pathway | Partners | Fold | FDR |
|---|---|---|---|
| Epigenetic regulation of gene expression | 5 | 13.7× | 5e-03 |
Disease & clinical
Clinical variants and AI predictions
ClinVar
34 variants total. Per-class counts are floors (≥ shown; pagination cap):
| Classification | Count (floor) |
|---|---|
| Pathogenic | 0 |
| Likely pathogenic | 0 |
| Uncertain significance | 30 |
| Likely benign | 0 |
| Benign | 0 |
Top pathogenic / likely-pathogenic (0)
SpliceAI
505 predictions. Top by Δscore:
| Variant | Effect | Δscore |
|---|---|---|
| 16:30570432:ATCTC:A | acceptor_gain | 0.9900 |
| 16:30570434:CTC:C | acceptor_gain | 0.9900 |
| 16:30570437:C:CC | acceptor_gain | 0.9900 |
| 16:30570437:CTGG:C | acceptor_loss | 0.9900 |
| 16:30570438:T:A | acceptor_loss | 0.9900 |
| 16:30571044:AGGAT:A | donor_gain | 0.9900 |
| 16:30571427:CTCT:C | donor_loss | 0.9900 |
| 16:30571428:TCTCA:T | donor_loss | 0.9900 |
| 16:30571429:CTCA:C | donor_loss | 0.9900 |
| 16:30571430:TCA:T | donor_loss | 0.9900 |
| 16:30571431:CACCG:C | donor_loss | 0.9900 |
| 16:30571432:ACCGA:A | donor_loss | 0.9900 |
| 16:30571433:C:A | donor_loss | 0.9900 |
| 16:30572120:ACC:A | donor_gain | 0.9900 |
| 16:30572121:CCC:C | donor_gain | 0.9900 |
| 16:30570435:TC:T | acceptor_gain | 0.9800 |
| 16:30570436:CC:C | acceptor_gain | 0.9800 |
| 16:30570446:C:CT | acceptor_gain | 0.9800 |
| 16:30571426:GCTCT:G | donor_loss | 0.9800 |
| 16:30571432:A:AC | donor_gain | 0.9800 |
| 16:30571433:C:CC | donor_gain | 0.9800 |
| 16:30572121:CCCCT:C | donor_gain | 0.9800 |
| 16:30572116:ACTTA:A | donor_loss | 0.9700 |
| 16:30572117:CTTAC:C | donor_loss | 0.9700 |
| 16:30572118:TTA:T | donor_loss | 0.9700 |
| 16:30572119:TA:T | donor_loss | 0.9700 |
| 16:30572120:AC:A | donor_gain | 0.9700 |
| 16:30572121:CC:C | donor_gain | 0.9700 |
| 16:30571385:C:A | donor_gain | 0.9600 |
| 16:30571433:CCGAG:C | donor_gain | 0.9600 |
AlphaMissense
1774 scored. Top likely-pathogenic:
| Variant | Protein change | am_pathogenicity |
|---|---|---|
| 16:30570087:G:C | F220L | 1.000 |
| 16:30570087:G:T | F220L | 1.000 |
| 16:30570089:A:G | F220L | 1.000 |
| 16:30570171:G:C | F192L | 1.000 |
| 16:30570171:G:T | F192L | 1.000 |
| 16:30570173:A:G | F192L | 1.000 |
| 16:30570088:A:G | F220S | 0.999 |
| 16:30570146:G:C | H201D | 0.999 |
| 16:30570172:A:G | F192S | 0.999 |
| 16:30570089:A:T | F220I | 0.998 |
| 16:30570110:A:G | C213R | 0.998 |
| 16:30570114:G:C | F211L | 0.998 |
| 16:30570114:G:T | F211L | 0.998 |
| 16:30570116:A:G | F211L | 0.998 |
| 16:30570132:G:C | H205Q | 0.998 |
| 16:30570132:G:T | H205Q | 0.998 |
| 16:30570144:G:C | H201Q | 0.998 |
| 16:30570144:G:T | H201Q | 0.998 |
| 16:30570146:G:T | H201N | 0.998 |
| 16:30570172:A:C | F192C | 0.998 |
| 16:30570173:A:T | F192I | 0.998 |
| 16:30570194:A:G | C185R | 0.998 |
| 16:30571510:C:A | W40C | 0.998 |
| 16:30571510:C:G | W40C | 0.998 |
| 16:30570060:G:C | H229Q | 0.997 |
| 16:30570060:G:T | H229Q | 0.997 |
| 16:30570062:G:C | H229D | 0.997 |
| 16:30570075:G:C | F224L | 0.997 |
| 16:30570075:G:T | F224L | 0.997 |
| 16:30570077:A:G | F224L | 0.997 |
dbSNP variants (sampled 300 via entrez): RS1000122027 (16:30575603 G>A), RS1000431698 (16:30575303 A>G), RS1000780617 (16:30581816 G>A), RS1000922024 (16:30581079 G>A,C), RS1001038511 (16:30573195 C>T), RS1001123878 (16:30574327 C>T), RS1001150489 (16:30575715 G>A), RS1001883987 (16:30575063 G>A,C), RS1002154695 (16:30573590 A>T), RS1002248114 (16:30574117 C>G), RS1002639502 (16:30581750 C>A), RS1002819260 (16:30576918 A>G), RS1003006183 (16:30570127 C>G,T), RS1003108156 (16:30576958 G>T), RS1003567834 (16:30570880 T>G)
Disease associations
OMIM: gene `` | disease phenotypes:
GenCC curated gene-disease
Mondo (0):
Orphanet (0):
HPO phenotypes
0 total (0 of 0 shown, HPO-id order):
GWAS associations
0 associations (top):
Drugs & pharmacology
Drug and pharmacology data
Is drug target: no
PharmGKB: 1 entry (VIP=true, CPIC=false)
CTD chemical–gene interactions
25 total (human), top 25 by PubMed support.
| Chemical | Actions (top 5) | PubMed papers |
|---|---|---|
| sodium arsenite | affects methylation, decreases expression | 2 |
| aristolochic acid I | increases expression | 1 |
| bisphenol F | affects cotreatment, increases expression | 1 |
| aminomethylphosphonic acid (AMPA) | decreases expression | 1 |
| sodium arsenate | decreases expression, increases abundance | 1 |
| ferrous chloride | decreases expression | 1 |
| di-n-butylphosphoric acid | affects expression | 1 |
| 2-methyl-2H-pyrazole-3-carboxylic acid (2-methyl-4-o-tolylazophenyl)amide | decreases expression | 1 |
| jinfukang | affects cotreatment, increases expression | 1 |
| Arsenic | increases abundance, decreases expression | 1 |
| Atrazine | decreases expression | 1 |
| Benzo(a)pyrene | increases methylation | 1 |
| Cisplatin | affects cotreatment, increases expression | 1 |
| Dichlorodiphenyl Dichloroethylene | decreases expression | 1 |
| Dexamethasone | affects cotreatment, increases expression | 1 |
| Diazinon | increases methylation | 1 |
| Estradiol | decreases expression | 1 |
| Indomethacin | affects cotreatment, increases expression | 1 |
| Smoke | decreases expression | 1 |
| Tobacco Smoke Pollution | decreases expression | 1 |
| Urethane | decreases expression | 1 |
| 1-Methyl-3-isobutylxanthine | affects cotreatment, increases expression | 1 |
| 2,4-Dichlorophenoxyacetic Acid | decreases expression | 1 |
| Cadmium Chloride | decreases expression | 1 |
| Okadaic Acid | decreases expression | 1 |
Clinical trials (associated diseases)
0 trials via MONDO — disease-level, not drug-specific.
Related Atlas pages
No linked Atlas pages yet — the cross-entity mesh grows as the corpus expands.